Eleventh-hour settlements with two…
Eleventh-hour settlements with two of the three generic drugmakers involved [...]
Haleon, a healthcare consumer and…
Haleon, a healthcare consumer and OTC brand company, has hired [...]
Compass Therapeutics shed half its…
Compass Therapeutics shed half its stock price this morning as [...]
Astellas Pharma has done some…
Astellas Pharma has done some spring cleaning of its pipeline, [...]
The FDA is awarding national…
The FDA is awarding national priority vouchers to Compass Pathways, [...]
After a series of setbacks for…
After a series of setbacks for Sanofi’s tolebrutinib, the French [...]
The FDA rejected two new products…
The FDA rejected two new products from AbbVie and Grace [...]
An established sales force and…
An established sales force and payer authorization criteria will fuel [...]
Daiichi Sankyo has postponed its…
Daiichi Sankyo has postponed its annual report by two weeks, [...]
Roche’s Genentech unit is…
Roche’s Genentech unit is launching a new multimedia campaign aimed [...]